-Hexosaminidase-Induced Activation of p44/42 Mitogen-Activated
Protein Kinase Is Dependent on p21Ras and Protein Kinase C and
Mediates Bovine Airway Smooth-Muscle Proliferation
The Crippled Children's Foundation Research Center; and Departments of Pediatrics and Pharmacology, College of Medicine, University of Tennessee, Memphis, Tennessee
Late-phase and sustained activation of p44/42MAPK has been reported to be a critical factor in cell mitogenesis. We therefore hypothesized that p44/42MAPK is involved in mannosyl-rich glycoprotein-induced mitogenesis in bovine airway smooth-muscle cells (ASMC). Treatment of adherent ASMC with
Mannosyl-rich lysosomal hydrolases ( Many receptor tyrosine kinases utilize p21Ras to bring Raf to the plasma membrane (13, 14). Farnesylation of p21Ras in the cysteine alanine alanine random amino acid (CAAX) motif enables the molecule to anchor to the membrane and recruit Raf-1 (15). Activation of Raf-1, which requires 14-3-3 proteins (18), is followed by phosphorylation and activation of mitogen-activated protein kinase (MAPK) kinase (MEK1) and MAPKs. In some cases, activation of MAPKs is partly dependent on PKC activation (19). In other cases, it has been proposed that PKC directly activates Raf-1, bypassing p21Ras (23). However, a recent report by Marais and coworkers (24) showed that Raf-1 activation by PKC requires Ras-guanosine triphosphate (GTP)-Raf complex formation. Whether or not p21Ras is involved in the Hex-induced activaton of p44/42MAPK is unknown. The objectives of this study were to examine the pattern of p44/42MAPK activation in response to Hex in ASMC, to establish its relationship to p21Ras and PKC, and to examine the role of p44/42MAPK activation in Hex-induced ASMC proliferation.
ASMC Culture Primary cultures of bovine ASM cells were prepared from bovine trachealis muscle as described previously (7). Direct immunofluorescence staining of the cells with a fluorescein isothiocyanate (FITC)-conjugated monoclonal antibody (mAb) to smooth-muscle isoactin (Sigma Chemical Co., St. Louis, MO) showed that cultures consisted of a homogeneous population of smooth-muscle cells (7). Cells at passages 1-7 were used for experiments. Western Blot Analysis of p44/42MAPK and Phospho-p44/42MAPK Confluent cells in 35-mm-well plates were starved for 48 h
in medium M199 (Cellgro; Mediatech, Washington, DC)
containing 0.4% (vol/vol) fetal bovine serum (FBS) (Hyclone Laboratories, Logan, UT). Cells were stimulated
with Hex A (50 nM) or vehicle (phosphate buffered saline,
[PBS]) for various periods at 37°C. When the effect of inhibitors was studied, the cells were treated with an inhibitor or vehicle at 37°C in a CO2 incubator, followed by Hex
A treatment for 2 h at the same temperature. The inhibitors studied were FPT III dissolved in 10% ethanol (1-10
µM, 4 h pretreatment; Calbiochem, San Diego, CA);
SCH-56582 dissolved in dimethylsulfoxide (DMSO) (1-10
µM, 4 h pretreatment, a gift from Dr. Robert Bishop, Schering-Plough Research Institute, Kenilworth, NJ); PD98059
dissolved in DMSO (1-5 µM, 30 min pretreatment; Calbiochem); and Tyrphostin AG-126 dissolved in DMSO (0.1-
0.2 µM, 3 h pretreatment; Calbiochem). Purified bovine
epididymal Ras Activation Cells were grown to approximately 70% confluence on chamber slides (Nunc, Inc., Naperville, IL). They were rinsed with Hanks' balanced salt solution (HBSS) and arrested over a period of 24 h in 1 ml of medium M199 containing 0.1% fetal bovine serum (FBS). This starvation protocol, as compared with the usual protocol of starving cells for 48 h in 0.4% FBS-containing media, does not affect signaling-activation pathways or cell proliferation induced by Hex A in bovine ASMC. The standard cells were then stimulated with Hex A (50 nM) or vehicle (PBS) for 10 min at 37°C. When the effect of inhibitors was studied, the cells were treated with FPT III (10 µM) for 24 h at 37°C in a CO2 incubator, followed by Hex A treatment for 10 min at the same temperature. The cells were washed for 5 min at 22°C three times in PBS to wash away the inhibitor, and fixed in 4% paraformaldehyde in PEM buffer (1,4-piperazinediethane sulfonic acid, 10 mM; EGTA, 5 mM; MgCl2, 2 mM; pH 6.8) containing 0.2% Triton X-100, and all washings were done with PBS. The cells were rehydrated in PBS containing 0.1% BSA for 30 min, and were treated for 1 h with PBS containing 3% BSA and 0.25% gelatin. A monoclonal anti-p21Ras antibody (F235 diluted 200-fold with PBS containing BSA and gelatin; Santa Cruz Biotechnology, Santa Cruz, CA) was applied to each well. After 1 h the cells were washed three times and exposed to biotinylated antimouse IgG (10 µg/ml; Vector Laboratories, Burlingame, CA) for 30 min in the dark. The cells were washed three times and rinsed quickly with water. A drop of Fluoromount-G (Fisher Scientific, Pittsburgh, PA) was applied to the cell surface, and coverslips were mounted. Slides were viewed by confocal fluorescence microscopy (MRC-1000 Lazer Scanning Confocal Imaging system, using an argon/krypton lamp; Bio-Rad, Hercules, CA) with a ×100 objective lens. Assessment of Proliferation To assess cell counts and cytotoxicity, a modified, colorimetric, tetrazolium salt reduction (3-[4,5-dimethylthiozol-2-yl]-2,5-diphenyl tetrazolium bromide [MTT]) assay was
used (25). After the cells reached confluence and were
contact-inhibited in microtiter wells, the medium was replaced with medium M199 containing 0.4% (vol/vol) FBS.
After a 48-h starvation, and without changing the medium, cells were exposed to the test inhibitors followed by Hex
A (50 nM) for 48 h. MTT at 5 mg/ml, Millipore filtered
(Sigma), dissolved in PBS, was added to the adherent cells
in microtiter wells (20 µl/well) at the end of the experimental period. After a 4-h incubation at 37°C, media were
removed from the microtiter wells, and acidified (0.04 M
HCl) 2-propane/isopropanol was added to the wells (200 µl/well). The plates were left at room temperature for 30 min, and were then read on an enzyme-linked immunoassay (ELISA) plate reader (EL340 Microplate; Bio-Tek Instruments, Winooski, VT) at a wavelength of 570 nm. The
values for the cell blank were obtained similarly, except
for MTT, which was substituted with PBS. Cell numbers
were derived from a standard curve generated from
known cell numbers. It has been shown that viable cell
numbers correlate with OD as determined with the MTT
assay; the tetrazolium ring is cleaved in active mitochondria, and the reaction therefore occurs only in living cells
(25). If the serum content is high ( Inhibition of MAPK Expression by Antisense DNA Oligonucleotide The effects on p44/42MAPK activities and cell proliferation in Hex-stimulated cells of transient transfection with antisense oligonucleotides were assessed under similar conditions to those described earlier. Antisense phosphorothioate-derivatized oligonucleotides (S-oligos, 18-mer), prepared through a polymerase chain reaction targeted to the translation initiation site (27) of human p44/42MAPK messenger RNA (mRNA) (28), were synthesized in the Molecular Resource Center at the University of Tennessee, Memphis. As controls, we used the following sense oligonucleotides: human p44MAPK (antisense), 5'-ATA GGC CGA GCT GAC CAT-3'; human p44MAPK (sense), 5'-ATG GTC AGC TCG GCC TAT- 3'. Subconfluent (70-80%) ASMC in 35-mm well plates were incubated for 24 h with Optimem medium (GIBCO-BRL, Gaithersburg, MD) containing 0.1% FBS, and were then either left untreated or were treated with antisense or sense oligonucleotides (1 µM) along with 3 µl/ml of lipofectamine (GIBCO-BRL) for 6 h at 37°C in a CO2 incubator. At the end of 6 h of incubation, FBS was added to achieve a final concentration of 10% (vol/vol), and cells were further incubated overnight for cell growth. All transfection media were removed, and fresh medium M199 containing 10% (vol/vol) FBS was added. The procedures were repeated twice (three 24-h pulse treatments). After the last pulse treatment, the medium was changed to M199 containing 0.4% (vol/vol) FBS. Cells were then stimulated with Hex A (50 nM, 2 h) for MAPK activity assays. Parallel experiments were set up for cell proliferation assays (72 h stimulation for cell counts). p44/42MAPK Kinase Enzyme Assay The assays were done with the BIOTRAK MAPK assay
system (Amersham) on both the membrane and cytosolic
fractions of samples. This assay system is based on the p42/
44MAPK-catalyzed transfer of the Data Analysis Experiments were performed in quadruplicate for cell proliferation assays. All experiments were repeated at least three times, and data were analyzed with the StatView 4.5 and SuperANOVA software systems (Abacus Concepts, Berkeley, CA) with Dunnett's post hoc test.
Activation of p44/42MAPK in Response to Hex A in Bovine ASMC To examine the pattern of p44/42MAPK activation, quiescent cells in 35-mm well plates were stimulated with Hex A (50 nM) or vehicle (PBS) for various times (0, 5, 15, and 30 min, and 1, 2, 4, 6, and 8 h). Western blot analysis of cell lysates was done with one of the polyclonal antibodies specific for p44/42MAPK or phospho-p44/42MAPK. The polyclonal anti-phospho-p44/42MAPK antibody detects only the catalytically activated forms that are phosphorylated at the Thr202 and Tyr204 residues (29, 30). Phospho-p44/42MAPK was increased in Hex-stimulated cells as compared with vehicle-treated cells at 30 min, 1 h, 2 h, and 4 h (Figure 1). The control blots for p44/42MAPK showed that there were equal amounts of p44/42MAPK proteins in the Hex-stimulated cells (Figure 1).
Effect of SCH-56582, PD98059, FPT III, AG-126, and Calphostin C on Hex-Induced Activation of p44/42MAPK Recently, Karpova and colleagues (31) reported that MEK1 is required for platelet-derived growth factor (PDGF)-induced ERK activation and DNA synthesis in bovine tracheal smooth-muscle cells. To establish the possible dependence of Hex-induced p44/42MAPK activation on MEK1, we tested the effect of PD98059, a specific inhibitor of MEK1 (32). Pretreatment of cells with PD98059 (5 µM) attenuated the activation of p44/42MAPK as judged by immunoblot analysis for phospho-p44/42MAPK (Figure 2A). Because of the known importance of sustained activation of MAPK in airway smooth-muscle proliferation (12), we examined the effect of inhibitors of MAPK activation at a later time point (2 h). To test for the possible involvement of p21Ras in Hex-induced p44/42MAPK activation, we tested inhibitors of farnesyl protein transferases that inhibit p21Ras activity (33, 34). Quiescent cells were pretreated with SCH-56582 (10 µM), FPT III (10 µM), or vehicle for 4 h before being stimulated with Hex A (50 nM) or vehicle for 2 h. Both SCH-56582 (Figure 2A) and FPT III (Figure 2B) attenuated the activation of p44/ 42MAPK as judged by immunoblot analysis for phospho-p44/42MAPK. The p42MAPK inhibitor Tyrphostin AG-126 (35) also slightly attenuated p44/42MAPK (Figure 2B). The concentrations of inhibitors were chosen to avoid cytotoxity in the long-term culture of cells in starvation media for proliferation assays. Possible regulation of Hex-induced p44/42MAPK activation by PKC was examined by pretreatment of cells with the PKC inhibitor calphostin C (0.2 µM, 2 h). Calphostin C completely inhibited Hex-induced p44/ 42MAPK activation (Figure 2C), at the same concentration that has been shown to inhibit PKC activity and Hex- induced ASMC proliferation (11).
p21Ras Activation by Hex A in Bovine ASMC Farnesylation of p21Ras is required for the subcellular localization of Ras to the plasma membrane, and is critical to the cell-transforming activity of Ras (34). To assess whether Hex indeed activates p21Ras, we examined fluorescent signals for p21Ras. In Hex-treated cells (50 nM, 10 min), fluorescent signals were aggregated at the plasma membrane of ASM cells (Figure 3B). The Ras activation was much more rapid (peak at 10 min) than the activation of MAPK (onset 30 min). These signals were abolished in cells that were pretreated with FPT III (10 µM, 24 h) (Figure 3D).
Effect of FPT III, SCH-56582, PD98059, and Tyrphostin AG-126 on Hex-Induced Bovine ASMC Proliferation To elucidate the roles of p21Ras, MEK1, and p44/42MAPK, we tested the effect of these agents on Hex-induced ASMC proliferation. Both farnesyl protein transferase inhibitors FPT III (1-10 µM, 34-75% inhibition) and SCH-56582 (1-10 µM, 88-100% inhibition), as well as the MEK1 inhibitor PD98059 (1-5 µM, 53-78% inhibition), significantly attenuated Hex-induced increases in cell number. Tyrphostin AG-126 (0.2 µM, 39%) had a modest inhibitory effect on Hex-induced ASMC proliferation (Figure 4).
Effect of p44MAPK Antisense S-Oligonucleotides on p44/42MAPK Activity, p44/42MAPK Protein Expression, and Hex-Induced Bovine ASMC Proliferation Subconfluent bovine ASMC in 35-mm-well plates were transiently transfected with either 18-mer sense or antisense S-oligonucleotides (1 µM, three 24-h pulses) according to the method described earlier. Cells were stimulated with Hex A (50 nM) or vehicle (PBS) for 2 h. Cell lysates were analyzed for MAPK activity using Biotrek (Amersham) assay kit. Antisense S-oligonucleotides effectively inhibited Hex-induced MAPK activity (Figure 5A). Antisense oligonucleotides directed to human p44MAPK (1 µM, two or three 24-h pulses) selectively inhibited MAPK protein expression, but not that of p72Syk in bovine ASMC (Figure 5B). Interestingly, human p44MAPK antisense S-oligonucleotides inhibited both p44MAPK and p42MAPK expression. These results are consistent with the findings of Sale and colleagues (36), and are explained by a high level of sequence homology among MAPKs. Cells responded well to growth factors (FBS and Hex) after repeated treatment with lipofectamine, and antisense S-oligonucleotides directed to p44MAPK (1 µM, three pulses) completely inhibited Hex-induced ASMC proliferation (Figure 5C).
The present study demonstrates that Hex-induced ASMC
proliferation is mediated by activation of the p21Ras/
MEK/p44/42MAPK pathway and PKC. The finding that p44/42MAPK antisense but not sense oligonucleotides inhibited Hex-induced expression of p44/ 42MAPK and ASMC proliferation supports our contention that p44/42MAPK mediates the mitogenic effect of Hex. Also supporting this view were our findings that tyrphostin AG-126 reduced MAPK activity and Hex-induced ASMC proliferation. It is known that MAPK is activated by MEK (13, 14). Since Hex-induced ASMC proliferation was inhibited by PD98059, it appears that Hex-induced p44/42MAPK activation depends on the activation of MEK. It is well established that MEK is activated by Raf-1 that is brought to the plasma membrane for activation by p21Ras (15). Raf-1 is also known to be activated by PKC (23). The farnesyl transferase inhibitors SCH-56582 and FPT III blocked Hex-induced anchorage of p21Ras to plasma membranes (Figure 3), and inhibited Hex-induced p44/42MAPK activation (Figures 2A and 2B) and ASMC proliferation (Figure 4), thus indicating an involvement of p21Ras in Hex-induced p44/42MAPK activation and ASMC proliferation. Regarding the method used to assess p21Ras activation in our study, the conventional method for estimating the GTP/guanosine diphosphate exchange ratio was not feasible, owing to the high basal levels of guanosine triphosphatase activating protein in bovine ASMC (D. B. Lew, unpublished data). Because the PKC inhibitor Calphostin C completely inhibited Hex-induced p44/42MAPK activation (Figure 2C) and ASMC proliferation (11), it appears that PKC is involved in Hex-induced, MAPK-mediated ASMC proliferation, probably via Raf-1 activation. Limited inhibition of Hex-induced p44/42MAPK activation by several agents was due to the lower concentrations of these agents used in our study as compared with the concentrations used in other studies (10 versus 100 µM for FPT III [33, 34], 5 versus 10- 50 µM for PD98059 [31, 32], and 0.2 versus 5 µM for Tyrphostin AG-126 [35], respectively). A necessarily noncytotoxic range of concentration of these inhibitors was chosen in the long-term culture system in starvation media used in our study, and one may therefore correlate the inhibitory effect of these agents on p44/42MAPK activation with their effect on cell proliferation induced by Hex. The mechanism(s) by which ligation of ASM-MR by
Hex leads to the activation of p21Ras is unknown. Most
recently, we have reported an interaction between ASM-MR and very late-acting antigen-5 ( We conclude that Hex stimulates a late-onset, sustained activation of p44/42MAPK in bovine ASMC. This activation depends on the activation of p21Ras, MEK1, and PKC. Inhibition of p44/42MAPK expression completely abolished Hex-induced proliferation in our study, suggesting that the activation of p44/42MAPK plays an important role in Hex-induced mitogenesis in bovine ASMC. Because Hex A is a physiologically significant inflammatory mediator that is secreted into the extracellular space in asthma (4), interfering in the process of activation of p21Ras, PKC, MEK1, and p44/42MAPK induced by Hex A may be a useful means of preventing hypertrophy/hyperplasia of ASM.
Address correspondence to: D. B. Lew, M.D., Associate Professor of Pediatrics, 50 North Dunlap Street, Rm. 401, Memphis, TN 38103. E-mail: dblews{at}pol.net (Received in original form September 4, 1998 and in revised form December 22, 1998). Abbreviations: airway smooth-muscle cells, ASMC; airway smooth-muscle mannose-recognizing receptors, ASM-MR; extracellular-regulated kinase, ERK; fetal bovine serum, FBS; hexosaminidase, Hex; mitogen-activated protein kinase, MAPK; MAPK kinase, MEK1; 3[4,5-dimethylthiozol-2-yl]- 2,5-dephenyl tetrazolium bromide, MTT; phosphate-buffered saline, PBS; protein kinase C, PKC.Acknowledgments: The authors thank Mr. Eric R. Brown and Mrs. Latonya Isaiah-Cotton for technical assistance, and Mrs. Mary Lenis for manuscript preparation. This work was supported by National Institutes of Health grants HL56812 (to D.B.L) and HL 19134 (to K.U.M.) and by a Crippled Children's Foundation Research Center Cannon Award (to D.B.L.).
1.
Torigoe, C.,
J. K. Inman, and
H. Metzger.
1998.
An unusual mechanism for
ligand antagonism.
Science
281:
568-572
2.
Schnyder, J., and
M. Baggiolini.
1978.
Secretion of lysosomal hydrolases by
stimulated and nonstimulated macrophages.
J. Exp. Med.
148:
435-450
3.
Lew, D. B.,
C. C. Leslie,
D. W. H. Riches, and
P. M. Henson.
1986.
Induction of macrophage lysosomal hydrolase synthesis and secretion by 4. Tonnel, A. B., M. Joseph, P. H. Gosset, E. Fourmer, and A. Capron. 1983. Stimulation of alveolar macrophages in asthmatic patients after local provocation test. Lancet 8339: 1406-1408 . 5. Murray, J. J., A. B. Tonnel, A. R. Brash, L. J. Roberts, P. Gosset, R. Workman, A. Capron, and J. A. Oates. 1986. Release of prostaglandin D2 into human airways during acute antigen challenge. N. Engl. J. Med. 315: 800-804 [Abstract].
6.
Lew, D. B.,
V. Chodimella, and
C. G. Murlas.
1990.
Guinea pig ozone-induced
airway hyperreactivity is associated with increased N-acetyl- 7. Lew, D. B., and M. C. Rattazzi. 1991. Mitogenic effect of lysosomal hydrolases on bovine tracheal myocytes in culture. J. Clin. Invest. 88: 1969-1975 . 8. Lew, D. B., E. Songu-Mize, S. E. Pontow, P. D. Stahl, and M. C. Rattazzi. 1994. A mannose receptor mediates mannosyl-rich glycoprotein-induced mitogenesis in bovine airway smooth muscle cells. J. Clin. Invest. 94: 1855-1863 . 9. Stahl, P. D., and R. A. B. Ezekowitz. 1998. The mannose receptor is a pattern recognition receptor involved in host defense. Curr. Opin. Immunol. 10: 50-55 [Medline].
10.
Lew, D. B.,
C. Nebigil, and
K. U. Malik.
1992.
Dual regulation by cAMP of
11.
Lew, D. B.,
E. R. Brown,
B. K. Dempsey,
H. M. Wright, and
K. U. Malik.
1997.
Contribution of PKC to
12.
Kelleher, M. D.,
M. K. Abe,
T.-S. O. Chao,
M. Jain,
J. M. Green,
J. Solway,
M. R. Rosner, and
M. B. Hershenson.
1995.
Role of MAP kinase activation in bovine tracheal smooth muscle mitogenesis.
Am. J. Physiol.
268:
L894-L901
13. Johnson, G. L., and R. R. Vaillancourt. 1994. Sequential protein kinase reactions controlling cell growth and differentiation. Curr. Opin. Cell Biol. 6: 230-238 [Medline]. 14. Clarke, P. R.. 1994. Switchhing off MAP kinases. Curr. Biol. 4: 647-650 [Medline]. 15. Leevers, S. J., H. F. Paterson, and C. J. Marshall. 1994. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane. Nature 369: 411-414 [Medline]. 16. Zhang, F. L., and P. J. Casey. 1996. Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65: 241-269 [Medline].
17.
Tschantz, W. R.,
E. S. Furfine, and
P. J. Casey.
1997.
Substrate binding is required for release of product from mammalian protein farnesyltransferase.
J. Biol. Chem.
272:
9989-9993
18.
Morrison, D..
1994.
14-3-3: modulators of signaling proteins?
Science
266:
56-57
19.
Qiu, Z.-H., and
C. C. Leslie.
1994.
Protein kinase C-dependent and -independent pathways of mitogen-activated protein kinase activation in macrophages by stimuli that activate phospholipase A2.
J. Biol. Chem.
269:
19480-19487
20. Franklin, R. A., A. Tordai, H. Patel, A. M. Gardner, G. L. Johnson, and E. W. Gelfand. 1994. Ligation of the T cell receptor complex results in activation of the ras/raf-1/MEK/MAPK cascade in human T lymphocytes. J. Clin. Invest. 93: 2134-2140 . 21. Izquierdo, M., S. J. Leevers, D. H. Williams, C. J. Marshall, A. Weiss, and D. Cantrell. 1994. The role of protein kinase C in the regulation of extracellular signal-regulated kinase by the T cell antigen receptor. Eur. J. Immunol. 24: 2462-2468 [Medline]. 22. Whelchel, A., J. Evans, and J. Posada. 1997. Inhibition of ERK activation attenuates endothelin-stimulated airway smooth muscle cell proliferation. Am. J. Respir. Cell Mol. Biol. 16: 589-596 [Abstract].
23.
Kolch, W.,
G. Heldecker,
G. Finkenzeller,
D. Marme, and
U. R. Rapp.
1993.
Protein kinase C
24.
Marais, R.,
Y. Light,
C. Mason,
H. Paterson,
M. F. Olson, and
C. J. Marshall.
1998.
Requirement of Ras-GTP-Raf complexes for activation of
Raf-1 by protein kinase C.
Science
280:
109-112
25. Mossman, T.. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63 [Medline]. 26. Zhang, Z., and G. Cox. 1996. MTT assay overestimates human airway smooth muscle cell number in culture. Biochem. Mol. Biol. Int. 38: 431-436 [Medline].
27.
Neckers, L., and
L. Whitesell.
1993.
Antisense technology: biological utility
and practical consideration.
Am. J. Physiol.
265:
L1-L12
28. Gonzalez, F. A., D. L. Raden, M. R. Rigby, and R. J. Davis. 1992. Heterogeneous expression of four MAP kinase isoforms in human tissues. FEBS Lett. 304: 170-178 [Medline]. 29. Payne, D. M., A. J. Rossomando, P. Martino, A. K. Erickson, J. H. Her, J. Shabanowitz, D. F. Hunt, M. J. Weber, and T. W. Sturgill. 1991. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10: 885-892 [Medline].
30.
Pang, L.,
T. Sawada,
S. J. Decker, and
A. R. Saltiel.
1995.
Inhibition of MAP
kinase blocks the differentiation of PC-12 cells induced by nerve growth
factor.
J. Biol. Chem.
270:
13585-13588
31.
Karpova, A. Y.,
M. K. Abe,
J. Li,
P. T. Liu,
J. M. Rhee,
W.-L. Kuo, and
M. B. Hershenson.
1997.
MEK1 is required for PDGF-induced ERK activation
and DNA synthesis in tracheal myocytes.
Am. J. Physiol.
272:
L558-L565
32.
Alessi, D. R.,
A. Cuenda,
P. Cohen,
D. T. Dudley, and
A. R. Saltiel.
1995.
PD98059 is a specific inhibitor of the activation of mitogen-activated proteinkinase in vitro and in vivo.
J. Biol. Chem.
270:
27489-27494
33. Leftheris, K., T. Kline, G. D. Vite, Y. H. Cho, R. S. Bhide, D. V. Patel, M. M. Patel, R. J. Schmidt, H. N. Weller, M. L. Andahazy, J. M. Carboni, J. L. Gullo-Brown, F. Y. Lee, C. Ricca, W. C. Rose, N. Yan, M. Barbacid, J. T. Hunt, C. A. Meyers, B. R. Seizinger, R. Zahler, and V. Manne. 1996. Develpoment of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity. J. Med. Chem. 39: 224-236 [Medline]. 34. Gibbs, J. B., and A. Oliff. 1997. The potential of farnesyltransferase inhibitors as cancer chemotherapeutics. Annu. Rev. Pharmacol. Toxicol. 37: 143-166 [Medline].
35.
Novogorsky, A.,
A. Vanchkin,
M. Patya,
A. Gazit,
N. Osherov, and
A. Levitzki.
1994.
Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors.
Science
264:
1319-1322
36. Sale, E. M., P. G. Atkinson, and G. J. Sale. 1995. Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J. 14: 674-684 [Medline]. 37. Meloche, S., K. Seuwen, G. Pages, and J. Pouyssegur. 1992. Biphasic and synergistic activation of p44MAPK (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol. Endocrinol. 6: 845-854 [Abstract]. 38. Marshall, C. J.. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185 [Medline].
39.
Hershenson, M. B.,
T.-S. O. Chao,
M. K. Abe,
I. Gomes,
M. D. Kelleher,
J. Solway, and
M. R. Rosner.
1995.
Histamine antagonizes serotonin and
growth factor-induced mitogen-activated protein kinase activation in bovine tracheal smooth muscle cells.
J. Biol. Chem.
270:
19908-19913
40.
Miller, M. J.,
L. Rioux,
G. V. Prendergast,
S. Cannon,
M. A. White, and
J. L. Meinkoth.
1998.
Differential effects of protein kinase A on Ras effector
pathways.
Mol. Cell. Biol.
18:
3718-3726
41. Lew, D. B., B. K. Dempsey, and K. U. Malik. 1998. Interaction of airway smooth muscle mannose receptor and VLA5 integrin via pertussis toxin sensitive mechanism. Pediatr. Res. 43: 8A . (Abstr.) .
42.
Crespo, P.,
X. Ningzhi,
F. S. William, and
J. S. Gutkind.
1994.
Ras-dependent activation of MAP kinase pathway mediated by G-protein
43.
Della Rocca, G. J., T. van Biesen, Y. Daaka, D. K. Luttrell, L. M. Luttrell,
and R. J. Lefkowitz.
1997.
Ras-dependent mitogen-activated protein kinase activation by G-protein-coupled receptors.
J. Biol. Chem.
272:
19125-19132
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
J. K. Bentley and M. B. Hershenson Airway Smooth Muscle Growth in Asthma: Proliferation, Hypertrophy, and Migration Proceedings of the ATS, January 1, 2008; 5(1): 89 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. WELSH, A. J. PEACOCK, M. MacLEAN, and M. HARNETT Chronic Hypoxia Induces Constitutive p38 Mitogen-activated Protein Kinase Activity That Correlates with Enhanced Cellular Proliferation in Fibroblasts from Rat Pulmonary But Not Systemic Arteries Am. J. Respir. Crit. Care Med., July 15, 2001; 164(2): 282 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Page, J. Li, and M. B. Hershenson p38 MAP kinase negatively regulates cyclin D1 expression in airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L955 - L964. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Lee, P. R. A. Johnson, M. Roth, N. H. Hunt, and J. L. Black ERK activation and mitogenesis in human airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, May 1, 2001; 280(5): L1019 - L1029. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Brown, C. A. Jones, L. A. Rooney, and G. H. Caughey Mast Cell Tryptase Activates Extracellular-Regulated Kinases (p44/p42) in Airway Smooth-Muscle Cells . Importance of Proteolytic Events, Time Course, and Role in Mediating Mitogenesis Am. J. Respir. Cell Mol. Biol., February 1, 2001; 24(2): 146 - 154. [Abstract] [Full Text] |
||||
![]() |
M. B. Hershenson and M. K. Abe Mitogen-Activated Signaling in Airway Smooth Muscle . A Central Role for Ras Am. J. Respir. Cell Mol. Biol., December 1, 1999; 21(6): 651 - 654. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |